Neogen (NEOG) EBITDA (2010 - 2026)

Neogen's EBITDA history runs 17 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• In Q1 2026, EBITDA fell 161.11% year-over-year to -$3.3 million; the TTM figure through Feb 2026 stood at $187.1 million (up 137.54% YoY), while the FY2025 annual figure was -$237.9 million, down 7819.47% from the prior year.
• EBITDA was -$3.3 million for Q1 2026 at Neogen, up from -$5.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $211.9 million in Q2 2025 to a low of -$457.5 million in Q4 2024.
• Historically, EBITDA has averaged -$12.0 million across 5 years, with a median of $6.1 million in 2022.
• The sharpest annual moves came in 2024 and 2025: EBITDA plunged 3262.7% in 2024, then surged 535.76% in 2025.
• A 5-year view of EBITDA shows it stood at -$7.7 million in 2022, then soared by 288.94% to $14.5 million in 2023, then slumped by 3262.7% to -$457.5 million in 2024, then soared by 98.82% to -$5.4 million in 2025, then soared by 38.63% to -$3.3 million in 2026.
• The last three EBITDA figures came in at -$3.3 million (Q1 2026), -$5.4 million (Q4 2025), and -$16.1 million (Q3 2025), per Business Quant data.